Stratasys Q3 2026 deep dive: Aerospace drives growth as large deals delay guidance
3D printing company Stratasys (NASDAQ:SSYS) beat Wall Street’s revenue expectations in Q3 2026, with sales up 4.1% year on year to $142.6 million. On the other hand, the company’s full-year revenue guidance of $558.5 million at the midpoint came in 1.2% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was $0.02 above analysts’ consensus estimates.
Is now the time to buy Stratasys? Find out in our full research report (it’s free for active Edge members).
Stratasys Q3 2026 highlights:
- Revenue $142.6 million vs S&P analyst consensus of $141.4 million (4.1% year-on-year growth, 0.9% beat)
- Adjusted EPS $0.04 vs S&P analyst consensus of $0.02 ($0.02 beat)
- Adjusted EBITDA $8.05 million vs analyst estimates of $6.90 million (5.6% margin, 16.7% beat)
- Revenue guidance The company dropped its revenue guidance for the full year to $558.5 million at the midpoint from $570 million, a 2% decrease
- Adjusted EPS guidance Management lowered its full-year adjusted EPS guidance to $0.11 at the midpoint, a 4.3% decrease
- EBITDA guidance $25 million at the midpoint for the full year, below analyst estimates of $25.3 million
- Operating margin -7.7%, up from -16.6% in the same quarter last year
- Market capitalization $508.9 million
StockStory’s take
Stratasys’ third quarter results prompted a negative market response, despite revenue and non-GAAP profit exceeding Wall Street expectations. Management attributed revenue growth to continued momentum in aerospace and defense (A&D), which saw more than 35% year-over-year growth, alongside gains in automotive and dental segments. CEO Yoav Zeif pointed to the company’s transition from rapid prototyping toward manufacturing as the primary driver, with recurring revenue from large industrial customers such as General Motors and new product launches like the F870 system supporting the quarter.
Looking ahead, Stratasys lowered its full-year outlook, citing longer sales cycles for large manufacturing deals and increased timing variability. Management noted that although the pipeline for production-focused applications remains robust, the shift toward larger, more complex orders means deals are taking longer to close, impacting near-term revenue expectations. CFO Eitan Zamir emphasized that “the reduction in revenue guidance is due to few large deals that were pushed further,” while Zeif maintained confidence in the company’s manufacturing-focused strategy and demand across its highest value verticals.
Key insights from management’s remarks
Management highlighted that growth was fueled by A&D and automotive, while delays in closing large deals and a shift away from rapid prototyping influenced the updated outlook.
- Aerospace and Defense momentum: A&D delivered over 35% year-over-year growth, driven by significant new and follow-on defense orders. Management linked this to industry trends like onshoring and supply chain resilience, with customers increasingly qualifying Stratasys platforms for flight-grade applications and scaling programs in drones, space, and munitions.
- Automotive partnerships scaling: The expanded relationship with General Motors saw Stratasys printers deployed in more than 20 plants, supporting over 5,000 factory floor applications in 2026 and delivering measurable cost and efficiency benefits. The newly launched F870 system was adopted by automotive leaders, including Toyota and Rivian.
- Growth in Stratasys Direct: The U.S.-based parts manufacturing business grew 9% over the prior year, with strong demand from defense customers and increased output from the F3300 system. Enhanced post-processing capabilities and AI-driven workflow improvements are increasing order backlog and expanding the value proposition for complex manufacturing contracts.
- Dental business milestones: Regulatory approval in India and new partnerships with labs like DDS Lab and Glidewell position Stratasys for future growth in dental applications, particularly with its TrueDent material and digital denture solutions targeting large-scale markets.
- Business model transition: The company continues to shift away from low-end rapid prototyping in favor of recurring industrial production revenue, resulting in more variability in consumables sales and longer sales cycles for larger, multi-system deals.
Drivers of future performance
Stratasys’ forward guidance is shaped by the timing of large production deals, a focus on high-value verticals, and ongoing cost discipline.
- Longer sales cycles: Management expects the transition to larger, production-focused orders to lengthen deal timelines and increase quarter-to-quarter variability. Zeif explained that while demand is strong, “the nature of the business is changing,” with more multi-system and recurring revenue deals in the pipeline.
- Continued investment in manufacturing: The company remains committed to R&D and technology upgrades, especially in FDM and SAF platforms, aiming to strengthen its leadership in industrial additive manufacturing even as some deals are delayed.
- Cost management focus: Zamir reiterated that operating expenses will be tightly controlled, with reductions in discretionary spend but ongoing investment in growth initiatives. The company’s debt-free balance sheet and positive operating cash flow provide financial flexibility for both organic and inorganic growth opportunities.
Catalysts in upcoming quarters
Going forward, the StockStory team will track (1) the closing and timing of large-scale production contracts in aerospace and automotive, (2) further adoption of new platforms like the F870 and expansion of Stratasys Direct’s complex manufacturing services, and (3) growth in dental and other emerging verticals following new product launches and regulatory wins. The company’s progress on integrating AI-driven workflow improvements and executing its manufacturing-focused strategy will also be important markers.
Stratasys currently trades at $5.86, down from $6.54 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).
Now could be the perfect time to invest in these stocks
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month, free. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.